Bayer Germany Reverse-Switches Phytohustil, Expands Iberogast
Bayer Vital is taking the unusual step to reverse-switch its Phytohustil range of herbal cough medicines in Germany, to strengthen the role of pharmacy in ensuring consumers access the right products for their needs. The company is also launching a new celandine-free addition to its embattled Iberograst brand of herbal gastrointestinal medicines.
You may also be interested in...
Bayer stepped up its Consumer Health innovation efforts in 2020 in line with its turnaround plan for the business, and now has more than 100 projects in development.
Lockwood-Taylor will start post on 1 August while continuing as North America consumer health chief. Also in North America, Dave Tomasi adds chief commercial officer post and Jeff Jarrett moves to chief marketing officer.
The health care and crop science conglomerate will pay up to $10.9bn to resolve most Roundup claims, but still has capital to do bolt-on deals like last year’s BlueRock cell therapy buy.